Mouthwash Recall: Missing or Illegible Lot and Expiration Date Coding
Haleon is recalling Parodontax mouthwash due to missing or illegible lot and expiration date coding on bottles. Approximately 84,764 bottles were distributed nationwide.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: This is an FDA Class III recall involving a documentation and labeling issue (missing or illegible lot and expiration date coding) with no reported illnesses, injuries, or inherent product defect. Per the rubric, documentation issues without health hazards are classified as Low (1).
Plain-English summary
Haleon US Holdings LLC is recalling Parodontax mouthwash (Active Gum Health, Mint flavor, 16.9 FL OZ / 500 mL bottles) due to labeling issues affecting product traceability and consumer information.
Some bottles may have missing or illegible lot number and expiration date coding. The affected lot is #0665363 with expiration date 08/31/2027. Approximately 84,764 bottles have been distributed to consumers nationwide.
Consumers who have purchased this product should verify that the lot number and expiration date are clearly visible on their bottles. If the information is missing or illegible, consumers should contact Haleon US Holdings LLC or their retailer for further instructions.
The recalled product
- Product
- PARODONTAX (CETYLPYRIDINIUM CHLORIDE)
- Brand
- PARODONTAX
- Manufacturer
- Haleon US Holdings LLC
- Category
- Drug — Mouthwash
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 0665363
- Exp 08/31/2027. Lot number and Exp Date may not appear on the 500 mL bottle.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- LowBusulfan Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27